Vitamin B12 is a water soluble vitamin necessary for the bone marrow to produce red blood cells
Semaglutide and tirzepatide are "upstream" they act on incretin receptors to influence appetite regulation, gastric emptying, and glucose-dependent insulin secretion
April 22, 2026: Removed from Category 2 On April 15, 2026, the FDA published a 503A category revision removing 12 peptides from Category 2 effective seven calendar days later (April 22)

Side Effects & Safety Profile: A Research Perspective Tesamorelin Side Effects Fluid retention/edema related to IGF-1 rise and sodium reabsorption Arthralgia (joint discomfort) common with elevated GH Glucose dysregulation potential insulin resistance at higher doses Injection site reactions redness, swelling at the subcutaneous administration site Rare: peripheral neuropathy, carpal tunnel symptoms in long protocols Sermorelin Side Effects Mild injection site irritation most common and typically transient Flushing or warmth at the injection site Rare: headache or dizziness post-injection Minimal systemic effects best-in-class safety profile among GHRH analogs Both peptides carry a theoretical risk of promoting insulin resistance at excessive GH levels a standard consideration in any GH-elevating research
If the resulting injection volume is too large, you may want to start with a fresh vial and use less water
Contaminant risk from unregulated manufacturing: Because BPC-157 products are not FDA-regulated, manufacturing standards vary enormously